Artificial intelligence to help develop new Parkinson's treatments

The project, which The Cure Parkinson's Trust contributed to, was submitted to the inaugural Benevolent AI Award – a competition run with the Association of Medical Research Charities (AMRC). Parkinson's UK's research proposal, which demonstrated how AI technology could solve specific research challenges in Parkinson's, was chosen to receive AI-driven research support from BenevolentAI, one of Europe's largest private AI companies. The project will use BenevolentAI platform's capabilities to reason, deduce and suggest entirely new treatments for Parkinson's. The aim is to identify at least three currently available medicines that can be repurposed to address Parkinson's, and two brand-new ways to treat the condition with new drugs. There have been no major breakthroughs in Parkinson's treatments in the last 50 years.